List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 494 studies with search of: "Treatment Experienced" [CONDITION] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Not yet recruiting An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic HCV-1 and HIV-1
Conditions: Genotype 1 Chronic Hepatitis C;   Treatment naïve With HCV-1/HIV-1 Coinfection;   Treatment Experienced With HCV-1/HIV-1 Coinfection
Interventions: Drug: Telaprevir;   Drug: Pegylated Interferon alfa-2a;   Drug: Ribavirin
2 Active, not recruiting Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Conditions: HIV Infections;   Treatment Experienced
Interventions: Biological: DNA + HIV-rAd5 vaccine;   Drug: ART intensification (raltegravir);   Drug: ART intensification (maraviroc)
3 Active, not recruiting A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome;   HIV Lipodystrophy Syndrome;   Lipodystrophy;   Dyslipidemia;   Osteoporosis;   Osteopenia
Intervention:
4 Completed Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
Conditions: HIV;   HIV Infections
Intervention: Behavioral: pharmaceutical care
5 Completed
Has Results
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   AIDS Virus;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus
Intervention: Drug: darunavir (DRV, TMC114)
6 Recruiting Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
7 Active, not recruiting Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Conditions: HIV Infections;   HIV Positive;   Pregnant Women
Intervention:
8 Completed Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
Conditions: HIV Seropositivity;   HIV Infection
Intervention: Drug: (Ampligen) polyI-polyC12U
9 Terminated Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
Conditions: HIV-Associated Lipodystrophy;   HIV Infections
Intervention: Device: poly-L-lactic acid
10 Active, not recruiting Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Recombinant Human Growth Hormone;   Drug: Rosiglitazone;   Drug: Recombinant Human Growth Hormone and Rosiglitazone;   Drug: Placebo human growth hormone and placebo rosiglitazone
11 Terminated Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
Conditions: HIV-Associated Lipodystrophy Syndrome;   HIV Infections
Intervention: Drug: Pioglitazone
12 Completed Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection;   HIV-1 Infection
Interventions: Procedure: Cheek cells sample;   Procedure: Blood sample
13 Recruiting Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome
Conditions: HIV (Human Immunodeficiency Virus);   Metabolic Syndrome;   HIV Infections
Intervention: Behavioral: Dietary Intervention
14 Recruiting A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Conditions: HIV;   HIV Infections;   Pregnancy
Interventions: Drug: TMC114 (darunavir);   Drug: ritonavir;   Drug: TMC125 (etravirine);   Drug: TMC278 (rilpivirine)
15 Recruiting Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
16 Completed Profile of HIV Seropositive Patients
Conditions: HIV Infection;   HIV Infections
Intervention:
17 Completed Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss
Conditions: HIV Infections;   Unintended Weight Loss;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
18 Completed Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Conditions: HIV-1;   HIV Infections
Intervention: Drug: Raltegravir
19 Active, not recruiting Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
Conditions: HIV;   HIV Infections
Interventions: Biological: ZFN modified T cells;   Other: Structured Treatment Interruption
20 Recruiting Statin Therapy to Improve Atherosclerosis in HIV Patients
Conditions: Cardiovascular Disease;   HIV;   Atherosclerosis;   Inflammation;   Statins, HMG-CoA;   HIV Infections
Interventions: Drug: atorvastatin;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options